Author/Editor
Dr. David Eifrig
Publisher
Stansberry Research
Description
New healthcare-focused “upgrade” newsletter launched by Eifrig in 2022, aims to generate market-doubling returns from pharma and other medical-sector stocks.
If you’ve subscribed to Prosperity Investor, please click the stars below to indicate your rating for this newsletter, and please share any other feedback about your experience using the comment box below.
Investment Performance
Rating from 1 votes
Rating: 2.0/5. From 1 vote.
Please wait...
Your vote
- 5 Stars 0 Votes
- 4 Stars 0 Votes
- 3 Stars 0 Votes
- 2 Stars 1 Votes
- 1 Stars 0 Votes
Quality Of Writing/Analysis
Rating from 1 votes
Rating: 3.0/5. From 1 vote.
Please wait...
Your vote
- 5 Stars 0 Votes
- 4 Stars 0 Votes
- 3 Stars 1 Votes
- 2 Stars 0 Votes
- 1 Stars 0 Votes
Value For Price
Rating from 1 votes
Rating: 2.0/5. From 1 vote.
Please wait...
Your vote
- 5 Stars 0 Votes
- 4 Stars 0 Votes
- 3 Stars 0 Votes
- 2 Stars 1 Votes
- 1 Stars 0 Votes
Customer Service
Rating from 1 votes
Rating: 3.0/5. From 1 vote.
Please wait...
Your vote
- 5 Stars 0 Votes
- 4 Stars 0 Votes
- 3 Stars 1 Votes
- 2 Stars 0 Votes
- 1 Stars 0 Votes